Exit Options for an S-Corp Founder

Path A - cash asset sale.

Gain = $9,000,000 - $400,000 = $8,600,000. Assume capital treatment for illustration; inventory, receivables, and depreciation recapture are ordinary and will raise the blended rate, so treat 28.8% as a floor. Tax = $2,476,800; net $6,523,200, today, fully liquid and diversifiable.

Path B - ESOP.

• Cash: $2,700,000. Note: $6,300,000 over seven years at 6% = about $1,128,600 a year.
• Discount those payments at 8% - the note is unsecured, subordinated, and the buyer is a company now 100% leveraged - giving a present value near $5,875,000. Total risk-adjusted value ≈ $8,575,000, roughly a 5% haircut to the cash offer.
• Installment reporting spreads the $8.6 million gain across seven years. The present value of that deferral, discounted at 5%, is roughly $350,000-$400,000 - about the size of the haircut.

Conclusion: on expected value the two paths are close to a wash. The ESOP is an employee-and-legacy decision, not a tax arbitrage. If he wants liquidity, take the cash; if he wants the company to stay in the community and the employees to own it, negotiate hard - a shorter note, more cash up front, security and covenants, and a guarantee structure he can live with.

The advisor's tax case needs correcting. The Section 1042 rollover that ESOP proposals lean on requires qualified securities of a C corporation. This is an S corporation, so no rollover is available. Converting S to C solely to enable it gives up pass-through treatment permanently and should be modeled separately - it rarely pays for a single transaction. Also flag the real risk: 70% of his wealth would remain tied to the same cyclical manufacturer, with the ESOP's own repurchase obligation competing with his note for the same cash flow.

Quantify the delay before agreeing to it.

• EBITDA growing 7% a year reaches about $2.20 million in three years. At the same 5.0x multiple that is $11.0 million gross, versus $9.0 million today - and after tax, roughly $7.9 million versus $6.5 million.
• The hurdle: $6,523,200 invested at a 5% after-tax return for three years is $7.55 million. To beat selling now, he needs net proceeds of $7.55 million, which is about $10.6 million gross, which is roughly $2.12 million of EBITDA at 5.0x. The entire margin of safety in the delay is about $80,000 of EBITDA and the assumption that the multiple does not move.
• The asymmetry: a one-turn multiple compression (5.0x to 4.0x) on $1.8 million of EBITDA destroys $1.8 million - more than three years of growth creates at a constant multiple. Multiples on owner-dependent manufacturers compress, they do not reliably expand, especially when the buyer assumes the founder is leaving in 36 months.

Decision rules to write into the plan:

1. Accept the process, not the number. Get a letter of intent with a floor now; negotiate price against a formula rather than hoping for a re-run in three years.
2. De-risk while waiting. Take a distribution or a partial recapitalization to move cash out of the business. Concentration is the risk being carried, not the multiple.
3. Set tripwires that force action: any single customer above 25% of revenue, the loss of a second-in-command, a health event, or EBITDA of $2.0 million with a firm offer at 4.75x or better - sell.
4. Fix the business's sellability now: quality-of-earnings review, customer contracts assignable, management depth documented. That is what actually moves the multiple.

First, size the estate. After a sale: $6.5 million net proceeds + $2.6 million IRA + $0.9 million taxable + $1.2 million home ≈ $11.2 million, against $14 million of combined federal exclusion. There is likely no federal estate tax problem. Saying so out loud prevents an expensive, unnecessary plan.

Where it does matter:

• State estate or inheritance tax, which often applies at a far lower threshold than the federal exclusion and is the real exposure.
• Liquidity and administration, including the IRAs and any retained note.
• Equalization, which is a family-governance question before it is a tax question.

Treating the children equally. The business cannot be split without destroying it. Equalize with other assets, not with the company:

1. Value both sides at fair market value, documented by appraisal. Emeka receives the business interest or the cash equivalent; Nia receives a comparable share of the diversified portfolio and IRA.
2. If the business stake exceeds what the other assets can match, use life insurance in an irrevocable life insurance trust payable to Nia (or to a trust for both children) to close the gap. It is the only asset that creates liquidity at exactly the moment the gap appears.
3. Be careful with discounted gifts of minority interests to Emeka while Daniel retains control. The valuation discount is real, but it is also the fastest way to make a fairness promise look like a fairness story. Disclose the appraisal and the reasoning to both children, in writing, while he is alive.
4. If he wants to freeze value before a sale, a grantor-trust sale or a gift to a spousal-access trust works - but only if done well before a letter of intent exists, with an independent appraisal, and with the state estate tax in view. Do not let an aggressive freeze solve a federal problem he does not have.

Finally, if he dies before the sale, the estate owns the business. A buy-sell, key-person coverage, and a written succession plan are prerequisites to the retirement date, not afterthoughts.